Last update:
Clinical pharmacology news
Experimental anesthetic may also blunt pain at nonsedating doses
Common intravenous anesthetics such as propofol and etomidate usually require additional pain medicines. Propofol and etomidate enhance GABA-A receptors, which act as brakes on nerve-cell activity, but generally do not relieve ...
Nov 20, 2026
0
16
Commonly used drug kills leukemia cells early by acting mainly on RNA, not DNA
For more than two decades, azacitidine has been a major treatment for blood cancers such as high-risk myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The drug was thought to work through DNA, by stripping ...
Nov 20, 2026
0
14
Blood pressure medication more likely to prevent heart attacks and strokes than cause serious falls, study finds
A major study led by researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, has found that blood pressure-lowering medication is more likely to prevent serious cardiovascular events, ...
Nov 20, 2026
0
30
Why older adults take longer to bounce back—and what to do about it
A class of fatty acid molecules called prostaglandins may be responsible for why older adults often fail to recover muscle strength after illness or injury, while young adults quickly bounce back, a new study has found. Produced ...
Nov 20, 2026
0
15
'Pan-RAS molecular glue' is a safe and effective treatment for lung and pancreatic cancers
Results from the AURORAS-1 Phase I clinical trial of an anticancer drug called ERAS-0015 have shown that it is safe and has caused tumors to shrink in hard-to-treat diseases such as lung and pancreatic cancer.
Nov 20, 2026
0
38
Could an erectile dysfunction drug offer a new way to treat Alzheimer's?
A drug developed to treat erectile dysfunction might seem an unlikely treatment for Alzheimer's disease. But researchers are increasingly interested in whether medicines such as Viagra could also help protect the brain.
Nov 20, 2026
0
7
A doctor's guide to surviving—and enjoying—holiday feasting while on GLP‑1 medication
Thanksgiving and the winter holidays bring celebration, connection and plenty of opportunities to come together with family and friends.
Nov 20, 2026
0
4
MYC inhibitor drug targets cancer cells directly and via the immune system
In a series of experiments, researchers have found that an experimental MYC inhibitor drug not only targets lung cancer cells directly but also makes cancer cells easier for the immune system to target and kill.
Nov 20, 2026
0
6
National study highlights flexible approaches to integrating pharmacists in aged care
A national study led by researchers from RMIT University and the University of Canberra (UC) has identified practical strategies to support the integration of on-site pharmacists in residential elder care homes across metropolitan, ...
Nov 20, 2026
0
3
Molecular glues: Unlocking new targets in cancer
The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska ...
Nov 20, 2026
0
2
Therapeutic antibody protects against all three pathogenic human coronaviruses
A therapeutic antibody (bispecific nanobody) developed by researchers at Georgia State University and collaborators neutralized all three highly pathogenic human coronaviruses (SARS-CoV, SARS-CoV-2 and MERS-CoV) and protected ...
Nov 19, 2026
0
7
One Health collaboration leads to potential targets against leishmaniasis, a parasitic disease
Leishmania parasites cause leishmaniasis. The disease is spread through the bite of an infected sand fly. While in the bloodstream, parasites invade host cells where they live and multiply.
Nov 19, 2026
0
5
Possible new treatment for Wilson disease seeks to minimize effects on mitochondria using metformin
Wilson disease is a rare genetic condition in which the liver loses the ability to effectively remove copper, allowing it to accumulate in the body. This toxic buildup affects the liver, brain, eyes and kidneys and is particularly ...
Nov 19, 2026
0
4
Neurosteroid offers clues to brain changes linked to depression
UT Southwestern Medical Center researchers and colleagues, including two at UT Dallas, have found evidence that pregnenolone—a naturally occurring steroid hormone the body produces from cholesterol—may alter patterns of communication ...
Nov 19, 2026
0
15
Can a small DNA fix protect against Parkinson's disease?
In 2021, researchers at Oslo University Hospital discovered that by switching off a specific gene in the roundworm C. elegans, they could protect a particular type of nerve cell from age-related degeneration. These are the ...
Nov 19, 2026
0
9
Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients
An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a Trojan Horse, has shown promising early results across diverse types of soft tissue sarcoma in a Phase I trial. The findings were presented ...
Nov 19, 2026
0
13
Two new 16-week tuberculosis regimens advance in clinical trial
Tuberculosis remains one of the world's deadliest infectious diseases, causing more than 1 million deaths each year. The development of new therapeutic regimens remains slow, costly and complex, while treatment remains lengthy ...
Nov 19, 2026
0
6
Experimental antibody-drug conjugate shows promising initial activity in head and neck cancers
The investigational antibody-drug conjugate (ADC) micvotabart pelidotin (MICVO, PYX-201) demonstrated promising antitumor activity and a manageable safety profile in a Phase I trial presented at the EORTC-NCI-AACR Symposium ...
Nov 19, 2026
0
6
Experimental GLS-1 inhibitor demonstrates antitumor activity in advanced treatment-resistant ovarian cancer
Combining the experimental therapy IACS-6274 with targeted therapy bevacizumab and paclitaxel chemotherapy showed promising antitumor activity in a Phase I trial of patients with advanced platinum-resistant ovarian cancer, ...
Nov 19, 2026
0
4
CBD oil offers no behavioral benefit for youths with intellectual disability, new study finds
Cannabis contains two key compounds that act on the brain: cannabidiol (CBD) and tetrahydrocannabinol (THC). Although both interact with the body's endocannabinoid system, the outcomes of consuming them are poles apart. THC ...
Inspired by 'Flowers for Algernon,' experimental nose drops improve memory in mice
Researchers at the University of Sydney have developed experimental nose drops that enhance learning and memory in aged mice while also preventing memory loss in a mouse model of Alzheimer's disease. The treatment uses mRNA ...
Nov 18, 2026
0
514
Novel compound eases paralysis and activates nerve repair pathways in multiple sclerosis mouse model
A new derivative of a natural compound reduced symptoms associated with multiple sclerosis and promoted the central nervous system's regenerative pathways in a mouse model, report researchers at the University of Illinois ...
Nov 18, 2026
0
18
How research paved the way for progress in a rare form of ALS
An experimental ALS drug that grew out of basic and clinical research at Columbia University's Vagelos College of Physicians and Surgeons may soon become available for patients with a rare and aggressive form of the disease.
Nov 18, 2026
0
12
No clear benefit from two drugs intended to increase spontaneous birth after induction in first-time moms
There is no clear evidence that hyoscine butylbromide or sodium bicarbonate improves spontaneous vaginal birth rates (without the assistance of forceps or vacuum) in first-time moms after induction of labor, finds a large ...
Nov 18, 2026
0
9
























